Hot Features
Connect Biopharma Holdings Limited operates as a clinical-stage biopharmaceutical company in the United States. It develops rademikibart, a human monoclonal IgG4 antibody directed against IL-4Ra in two Phase 2 trials for the treatment of acute exacerbations of asthma and chronic obstructive pulmonar... Connect Biopharma Holdings Limited operates as a clinical-stage biopharmaceutical company in the United States. It develops rademikibart, a human monoclonal IgG4 antibody directed against IL-4Ra in two Phase 2 trials for the treatment of acute exacerbations of asthma and chronic obstructive pulmonary disease (COPD). The company was founded in 2012 and is headquartered in San Diego, California. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.06 | 2.81690140845 | 2.13 | 2.225 | 1.92 | 508999 | 2.03169662 | CS |
| 4 | -0.21 | -8.75 | 2.4 | 2.52 | 1.92 | 322258 | 2.11847125 | CS |
| 12 | -0.81 | -27 | 3 | 3.1494 | 1.92 | 263557 | 2.422587 | CS |
| 26 | -0.56 | -20.3636363636 | 2.75 | 3.82 | 1.92 | 211811 | 2.59375379 | CS |
| 52 | 1.2501 | 133.003511012 | 0.9399 | 3.82 | 0.93 | 217875 | 2.42236993 | CS |
| 156 | 1.06 | 93.8053097345 | 1.13 | 3.82 | 0.51 | 146030 | 1.77103913 | CS |
| 260 | -16.99 | -88.5818561001 | 19.18 | 29.2735 | 0.51 | 193870 | 2.56061782 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.